Fifteen years ago Olney and colleagues began using animal models to evaluate the effects of anesthetic and sedative agents (ASAs) on neurodevelopment. The results from ongoing studies indicate that, under certain conditions, exposure to these drugs during development induces an acute elevated apoptotic neurodegenerative response in the brain and long-term functional impairments. These animal models have played a significant role in bringing attention to the possible adverse effects of exposing the developing brain to ASAs when few concerns had been raised previously in the medical community. The apoptotic degenerative response resulting from neonatal exposure to ASAs has been replicated in many studies in both rodents and non-human primates, suggesting that a similar effect may occur in humans. In both rodents and non-human primates, significantly increased levels of apoptotic degeneration are often associated with functional impairments later in life. However, behavioral deficits following developmental ASA exposure have not been consistently reported even when significantly elevated levels of apoptotic degeneration have been documented in animal models. In the present work, we review this literature and propose a rodent model for assessing potential functional deficits following neonatal ASA exposure with special reference to experimental design and procedural issues. Our intent is to improve test sensitivity and replicability for detecting subtle behavioral effects, and thus enhance the translational significance of ASA models.
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Introduction
There has been increased awareness in recent years of the possibility that exposing the developing brain to anesthesia and/or sedation may result in deleterious effects on brain function and cognitive capabilities. For example, DiMaggio and colleagues (DiMaggio, Sun, Ing, & Li, 2012) conducted a Bayesian analysis of selected studies from 2008 to 2012 on children exposed to various anesthetics as infants (Bartels, Althoff, & Boomsma, 2009; DiMaggio, Sun, Kakavouli, Byrne, & Li, 2009; Guerra et al., 2011; Ing et al., 2012; Kalkman et al., 2009; Rozé et al., 2008; Wilder et al., 2009) , and concluded that there is a modest but elevated risk of adverse behavioral/developmental outcomes due to early anesthesia exposure. Subsequent research has provided additional evidence that anesthesia may, or may not, be associated with long-term adverse effects on behavioral and cognitive development, with outcomes being dependent on certain critical parameters (see (Creeley, 2016) for a review). Taken together, these studies suggest that early multiple exposures to surgery/anesthetics may increase the risk of adverse neurobehavioral outcomes, but a single exposure likely does not (Davidson et al., 2016; DiMaggio, Sun, & Li, 2011; Flick et al., 2011; Sprung et al., 2012; Sun et al., 2016) . However, it remains unclear if a dose threshold exists for a single exposure to induce adverse
